Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Accesswire
*Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of..
*Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of..
Projected to Exhibit a Remarkable Expansion Rate, the Global Silica Analyser Market is Estimated to Grow Significantly with the..
· *mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222*
·..